G
Gustavo Jankilevich
Researcher at University of Buenos Aires
Publications - 8
Citations - 72
Gustavo Jankilevich is an academic researcher from University of Buenos Aires. The author has contributed to research in topics: Gestational trophoblastic disease & Capecitabine. The author has an hindex of 4, co-authored 8 publications receiving 53 citations.
Papers
More filters
Journal ArticleDOI
Low molecular weight hyaluronan induces migration of human choriocarcinoma JEG-3 cells mediated by RHAMM as well as by PI3K and MAPK pathways
Marilina Mascaró,Matías Pibuel,Silvina Lompardía,Mariángeles Díaz,Elsa Zotta,Maria Ines Bianconi,Néstor Lago,S. Otero,Gustavo Jankilevich,Elida Alvarez,Silvia E. Hajos +10 more
TL;DR: It is shown that HA is able to enhance the expression of extravillous trophoblast markers and also to induce migration of JEG-3 cells, the latter mediated by RHAMM as well as PI3K and MAPK pathways, which indicate a novel regulatory mechanism for CC cell biology.
Journal ArticleDOI
Treatment of patients with gestational trophoblastic neoplasia (GTN) in 12 South America referral centers: Results after 10 years since international FIGO consensus.
Gustavo Jankilevich,Elza Maria Hartmann Uberti,Antonio Braga,Maria Ines Bianconi,Izildinha Maestá,Maurício Viggiano,Sue Sun,Rafael Cortés Charry,Aleydah Salazar,Bruno Maurizio Grillo,Juandyr Moreira de Andrade,Eduardo Silveira,José Mauro Madi,Lourdes Rodriguez,S. Otero,Jorge Rezende-Filho,Maria do Carmo Fajardo,Joffre Amim-Junior,Sergio Lunardon Padilha +18 more
TL;DR: Gestational Trophoblastic Disease is a curable disease and initial pathological results of previous gestation were complete Hydatidiform Mole in 971 cases, partial HM in 125 cases, choriocarcinoma in 131 cases, and another histopathological diagnosis in 37 c...
Journal ArticleDOI
Successful salvage of a relapsed high risk gestational trophoblastic neoplasia patient using capecitabine.
TL;DR: The use of Capecitabine and the multidisciplinary management of this population should be taken into account for patients at high risk of relapsing to EP/EMA because of its efficacy and little toxicity.
Journal Article
Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.
Maria Ines Bianconi,S. Otero,Oriana Moscheni,Lucia Alvarez,Claudio Storino,Gustavo Jankilevich +5 more
TL;DR: The compliance with international guidelines allows reach a successful treatment and follow-up in one Latin-American population and the outcome was related with inadequate initial treatment.
Journal ArticleDOI
Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America.
Izildinha Maestá,Marjory de Freitas Segalla Moreira,Jorge Rezende-Filho,Maria Ines Bianconi,Gustavo Jankilevich,S. Otero,Luz Angela Correa Ramirez,Luz Angela Correa Ramirez,Sue Yazaki Sun,Kevin M. Elias,Neil S. Horowitz,Antonio Braga,Ross S. Berkowitz +12 more
TL;DR: Trophoblastic disease centers in developing South American countries have achieved high remission rates in high-risk GTN, but early deaths remain an important problem, particularly in ultra-high- risk GTN.